Suicide-Specific Therapy App Effectively Cuts Suicidal Behavior in High-Risk Inpatients
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 14, 2025 -- A mobile phone app designed to deliver suicide-specific therapy reduces suicidal behavior among high-risk psychiatric inpatients, according to a study published online Aug. 8 in JAMA Network Open.
Craig J. Bryan, Psy.D., from The Ohio State University College of Medicine in Columbus, and colleagues evaluated the efficacy of a smartphone-based digital therapeutic intervention (OTX-202; Oui Therapeutics, Inc.) delivering suicide-focused cognitive behavioral therapy in reducing suicidal behavior among patients hospitalized for a suicide attempt or suicidal ideation. The analysis included 266 patients from six psychiatric inpatient units who were randomly assigned to a digital therapeutic intervention or a control application group each consisting of 12 sessions lasting 10 to 15 minutes each and followed to week 24.
The researchers found that time to first actual suicide attempt (the primary end point) was not significantly different across treatment groups (P = 0.06). Among the 170 participants with prior suicide attempts, the adjusted rate of follow-up suicide attempts was 58.3 percent lower in the digital therapeutic group versus the control application group (0.70 versus 1.68 attempts per person-year; rate ratio, 0.42) and the odds of clinical improvement were higher in the digital therapeutic group than the control application group (97.9 versus 87.5 percent; odds ratio, 7.59). There were significantly different trajectories of suicidal ideation between the digital therapeutic and control groups, with decreased suicidal ideation through week 24 in the digital therapeutic group, while suicidal ideation decreased through week 12 and then increased at week 24 in the control group. The suicide attempt rate among patients with a prior suicide attempt decreased by 14.0 percent for every digital therapeutic module completed.
"Although suicide-specific therapy is highly effective for reducing suicidal thoughts and urges, finding therapists who know how to do this lifesaving therapy after leaving the hospital can be challenging," Bryan said in a statement. "OTX-202 provides a possible solution to that problem."
Several authors disclosed ties to Oui Therapeutics, which funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Socioeconomic Deprivation Tied to Neurodegeneration in Combat Athletes
THURSDAY, Aug. 14, 2025 -- Athletes experiencing early-life socioeconomic disadvantage may have an increased risk for neurodegeneration from exposure to repetitive head injury...
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality...
2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes
THURSDAY, Aug. 14, 2025 -- From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.